Compound Profile

GHK Cu

Copper-binding tripeptide

GHK Cu is a naturally occurring copper binding tripeptide with a genuinely well supported topical cosmetic evidence base — including human RCTs for skin firmness, fine lines, and wound healing — plus a separate, much less evidenced injectable/RUO research peptide use.

Last reviewed:

B Moderate

Monograph visual

GHK Cu

Generated profile category visual

Where to go next — guides & comparisons

Continue reading

Regulatory status

2026 federal and state regulatory context

Last checked 2026 06 30

Topical cosmetic use is a legitimate, established commercial channel. Injectable/systemic use falls into the same RUO regulatory category as other research peptides.

Regulatory changelog

  • 2026 02: Injectable GHK Cu named among peptides expected to move toward Category 1 compounding status per HHS/FDA announcement. Mid 2026: Formal rulemaking still pending.

Quick Stats

Evidence level

Moderate evidence

Typical onset

Varies by prep

Safety rating

Use extra caution: Use caution

Best for

Copper Cofactor Delivery (Lysyl Oxidase And Superoxide Dismutase), Collagen And Elastin Synthesis Stimulation, Antioxidant And Anti Inflammatory Activity

Avoid / review if

Wilson's Disease Or Other Copper Metabolism Disorders, Known Copper Allergy Or Hypersensitivity, Pregnancy/Breastfeeding (No Established Safety Data)

Safety & Cautions

Review before use if any apply: Wilson's Disease Or Other Copper Metabolism Disorders, Known Copper Allergy Or Hypersensitivity, Pregnancy/Breastfeeding (No Established Safety Data).

Evidence Summary

B Moderate

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedCopper Cofactor Delivery (Lysyl Oxidase · Superoxide Dismutase) · Collagen And Elastin Synthesis Stimulation

Research maturity: More interpretablemain contexts: Copper Cofactor Delivery (Lysyl Oxidase And Superoxide Dismutase) · Collagen And Elastin Synthesis Stimulation · Antioxidant And Anti Inflammatory Activity

Safety boundary: Safety note availableReview before use if any apply: Wilson's Disease Or Other Copper Metabolism Disorders, Known Copper Allergy Or Hypersensitivity, Pregnancy/Breastfeeding (No Established Safety Data).

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Moderate evidence

GHK Cu has a moderate evidence evidence rating.

Inflammation SupportLongevity
Effects
4
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

A

Strong

Multiple RCTs, consistent direction, adequate effect size

B

Moderate

Some RCTs or consistent observational data in humans

C

Preliminary / Mixed

Animal or in-vitro only, or conflicting human data

D

Traditional / Theoretical

Traditional use only; no controlled human trials

How GHK Cu Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How GHK Cu Works

How GHK Cu WorksGHK Cu acts on pathways via antioxidant, leading to copper cofactor delivery (lysyl oxidase and superoxide dismutase).GHK CuBiological pathwayAntioxidantCopper Cofactor Delivery (Lysyl Oxidase And Superoxide Dismutase)Observable outcome
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

Copper Cofactor Delivery (Lysyl OxidaseSuperoxide Dismutase)Collagen And Elastin Synthesis StimulationAntioxidant And Anti Inflammatory ActivityWound Healing Angiogenesis SupportCollagen And Elastin Remodeling

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the GHK Cu evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

⚠️ Sourcing Options Disabled for Safety

Direct product recommendations and affiliate links are suppressed for this compound due to its high caution or needs-review safety classification.

Evaluate the safety checks, contraindications, and potential medication interactions below under clinician supervision before use.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Compound profile context

How to interpret GHK Cu

GHK Cu dosage by use case, onset and duration, safety limits, and interactions for copper cofactor delivery (lysyl oxidase and superoxide dismutase), graded… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing GHK Cu, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.